Cardiovascular and autonomic alterations in rats with Parkinsonism induced by 6-OHDA and treated with L-DOPA

Life Sciences

Volumn 127, Issue , 2015, Pages 82-89

  Silva, A S ^a   Ariza, D ^a   Dias, D P M ^b   Crestani, C C ^c   Martins Pinge, M C ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Arterial pressure; Head up tilt; Heart rate; Prolopa; Variability

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; DOPAMINE; OXIDOPAMINE; ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIPARKINSON AGENT; BIOGENIC AMINE; LEVODOPA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PARKINSONISM; PRESSORECEPTOR REFLEX; RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CHEMICALLY INDUCED; DRUG EFFECTS; HEMODYNAMICS; METABOLISM; PARKINSON DISEASE, SECONDARY; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; ANTIPARKINSON AGENTS; AUTONOMIC NERVOUS SYSTEM; BAROREFLEX; BIOGENIC MONOAMINES; BLOOD PRESSURE; DOPAMINE; HEART RATE; HEMODYNAMICS; LEVODOPA; MALE; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, WISTAR; SYMPATHOLYTICS;

EID: 84925263337     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.01.032     Document Type: Article

References (52)

1. V. Adhiyaman, P. Hobson, and R.J. Meara Central and peripheral autonomic integrity in Parkinson's disease Age Ageing 37 2008 578 581
2. S. Akselrod, D. Gordon, F.A. Ubel, D.C. Shannon, A.C. Berger, and R.J. Cohen Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control Science 213 1981 220 222
3. D. Ariza, M.M. Lima, C.G. Moreira, P.A. Dombrowski, T.V. Avila, and A. Allemand et al. Intranigral LPS administration produces dopamine, glutathione but not behavioral impairment in comparison to MPTP and 6-OHDA neurotoxin models of Parkinson's disease Neurochem. Res. 35 2010 1620 1627
4. D. Ariza, L. Sisdeli, C.C. Crestani, R. Fazan Jr., and M.C. Martins-Pinge Dysautonomias in Parkinson's disease: cardiovascular changes and autonomic modulation in conscious rats after infusion of bilateral 6-Ohda in substantia nigra Am. J. Physiol. Heart Circ. Physiol. 308 2015 10.1152/ajpheart.00406.2014
5. F. Barbic, F. Perego, M. Canesi, M. Gianni, S. Biagiotti, and G. Costantino et al. Early abnormalities of vascular and cardiac autonomic control in Parkinson's disease without orthostatic hypotension Hypertension 49 2007 120 126
6. D. Bedette, R.A. Santos, and M.A. Fontes Cardiovascular reactivity after blockade of angiotensin AT1 receptors in the experimental model of tilting test in conscious rats Br. J. Pharmacol. 153 2008 966 971
7. B.P. Bejjani, I. Arnulf, S. Demeret, P. Damier, A.M. Bonnet, and J.L. Houeto et al. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible? Ann. Neurol. 47 2000 655 658
8. G.E. Billman Heart rate variability - a historical perspective Front. Physiol. 2 2011 86
9. W. Birkmayer, J. Knoll, P. Riederer, M.B. Youdim, V. Hars, and J. Marton Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study J. Neural Transm. 64 1985 113 127
10. N.V. da Cunha, P. Pinge-Filho, C. Panis, B.R. Silva, L. Pernomian, and M.D. Grando et al. Decreased endothelial nitric oxide, systemic oxidative stress, and increased sympathetic modulation contribute to hypertension in obese rats Am. J. Physiol. Heart Circ. Physiol. 306 2014 H1472 H1480
11. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909
12. S. Duty, and P. Jenner Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease Br. J. Pharmacol. 164 2011 1357 1391
13. S. Fahn The history of dopamine and levodopa in the treatment of Parkinson's disease Mov. Disord. 23 Suppl. 3 2008 S497 S508
14. V.M. Farah, E.D. Moreira, M.C. Irigoyen, and E.M. Krieger Baroreflex depression persists in the early phase after hypertension reversal Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 2001 R1620 R1626
15. D.S. Goldstein, C.S. Holmes, R. Dendi, S.R. Bruce, and S.T. Li Orthostatic hypotension from sympathetic denervation in Parkinson's disease Neurology 58 2002 1247 1255
16. M.W. Horstink, and P.K. Morrish Preclinical diagnosis of Parkinson's disease Adv. Neurol. 80 1999 327 333
17. W.H. Jost Autonomic dysfunctions in idiopathic Parkinson's disease J. Neurol. 250 Suppl. 1 2003 I28 I30
18. A.D. Korczyn Autonomic nervous system disturbances in Parkinson's disease Adv. Neurol. 53 1990 463 468
19. R.M. Kostrzewa, P. Nowak, J.P. Kostrzewa, R.A. Kostrzewa, and R. Brus Peculiarities of L: -DOPA treatment of Parkinson's disease Amino Acids 28 2005 157 164
20. A. Lipp, P. Sandroni, and P.A. Low Systemic postganglionic adrenergic studies do not distinguish Parkinson's disease from multiple system atrophy J. Neurol. Sci. 281 2009 15 19
21. J. Luthman, A. Fredriksson, E. Sundstrom, G. Jonsson, and T. Archer Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage Behav. Brain Res. 33 1989 267 277
22. A. Malliani, M. Pagani, F. Lombardi, and S. Cerutti Cardiovascular neural regulation explored in the frequency domain Circulation 84 1991 482 492
23. R.B. Mastelari, H.C. de Souza, A. Lenhard, F.M. de Aguiar Correa, and M.C. Martins-Pinge Nitric oxide inhibition in paraventricular nucleus on cardiovascular and autonomic modulation after exercise training in unanesthetized rats Brain Res. 1375 2011 68 76
24. C. Maurer, T. Mergner, J. Xie, M. Faist, P. Pollak, and C.H. Lucking Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease Brain 126 2003 1146 1163
25. N. Montano, T.G. Ruscone, A. Porta, F. Lombardi, M. Pagani, and A. Malliani Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt Circulation 90 1994 1826 1831
26. A.D. Mosnaim, R. Abiola, M.E. Wolf, and L.C. Perlmuter Etiology and risk factors for developing orthostatic hypotension Am. J. Ther. 17 2010 86 91
27. T. Muller, H. Hefter, R. Hueber, W.H. Jost, K.L. Leenders, and P. Odin et al. Is levodopa toxic? J. Neurol. 251 Suppl. 6 2004 VI/44 VI/46
28. D.H. Nicaretta, A.L. de Rosso, C. Maliska, and M.M. Costa Scintigraphic analysis of the parotid glands in patients with sialorrhea and Parkinson's disease Parkinsonism Relat. Disord. 14 2008 338 341
29. D.H. Nicaretta, J.S. Pereira, and M.L. Pimentel Autonomic disorders in Parkinson's disease Rev. Assoc. Med. Bras. 44 1998 120 122
30. C.W. Olanow Levodopa/dopamine replacement strategies in Parkinson's disease - future directions Mov. Disord. 23 Suppl. 3 2008 S613 S622
31. J. Oosting, H.A. Struijker-Boudier, and B.J. Janssen Validation of a continuous baroreceptor reflex sensitivity index calculated from spontaneous fluctuations of blood pressure and pulse interval in rats J. Hypertens. 15 1997 391 399
32. F.E. Padovan-Neto, M.B. Echeverry, V. Tumas, and E.A. Del-Bel Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease Neuroscience 159 2009 927 935
33. M. Pagani, R. Furlan, S. Dell'Orto, P. Pizzinelli, G. Lanzi, and G. Baselli et al. Continuous recording of direct high fidelity arterial pressure and electrocardiogram in ambulant patients Cardiovasc. Res. 20 1986 384 388
34. G. Paxinos, and C. Watson The Rat Brain Stereotaxic Coordinates 1998 Elsevier San Diego, California, USA
35. S. Przedborski Pathogenesis of nigral cell death in Parkinson's disease Parkinsonism Relat. Disord. 11 Suppl. 1 2005 S3 S7
36. F. Rahman, and D.S. Goldstein Quantitative indices of baroreflex-sympathoneural function: application to patients with chronic autonomic failure Clin. Auton. Res. 24 2014 103 110
37. A.B. Reksidler, M.M. Lima, P.A. Dombrowski, G.F. Barnabe, M.L. Andersen, and S. Tufik et al. Distinct effects of intranigral L-DOPA infusion in the MPTP rat model of Parkinson's disease J. Neural Transm. Suppl. 259-68 2009
38. R. Rubini, A. Porta, G. Baselli, S. Cerutti, and M. Paro Power spectrum analysis of cardiovascular variability monitored by telemetry in conscious unrestrained rats J. Auton. Nerv. Syst. 45 1993 181 190
39. S. Sarre, D. Vandeneede, G. Ebinger, and Y. Michotte Biotransformation of L-DOPA to dopamine in the substantia nigra of freely moving rats: effect of dopamine receptor agonists and antagonists J. Neurochem. 70 1998 1730 1739
40. J.B. Schulz, and B.H. Falkenburger Neuronal pathology in Parkinson's disease Cell Tissue Res. 318 2004 135 147
41. S.A. Smith, and J.J. Fasler Age-related changes in autonomic function: relationship with postural hypotension Age Ageing 12 1983 206 210
42. A.J. Stoessl Prevention and management of late stage complications in Parkinson's disease Can. J. Neurol. Sci. 19 1992 113 116
43. D.H. Streeten, and T.F. Scullard Excessive gravitational blood pooling caused by impaired venous tone is the predominant non-cardiac mechanism of orthostatic intolerance Clin. Sci. (Lond.) 90 1996 277 285
44. P. van de Borne, N. Montano, M. Pagani, R. Oren, and V.K. Somers Absence of low-frequency variability of sympathetic nerve activity in severe heart failure Circulation 95 1997 1449 1454
45. M.K. Walker, J.R. Boberg, M.T. Walsh, V. Wolf, A. Trujillo, and M.S. Duke et al. A less stressful alternative to oral gavage for pharmacological and toxicological studies in mice Toxicol. Appl. Pharmacol. 260 2012 65 69
46. L.M. Wing, and A.L. Tonkin Orthostatic blood pressure control and ageing Aust. NZ J. Med. 27 1997 462 466
47. J.P. Wolf, M. Bouhaddi, F. Louisy, A. Mikehiev, L. Mourot, and S. Cappelle et al. Side-effects of L-DOPA on venous tone in Parkinson's disease: a leg-weighing assessment Clin. Sci. (Lond.) 110 2006 369 377
48. T. Ziemssen, and H. Reichmann Non-motor dysfunction in Parkinson's disease Parkinsonism Relat. Disord. 13 2007 323 332
49. T. Ziemssen, and H. Reichmann Cardiovascular autonomic dysfunction in Parkinson's disease J. Neurol. Sci. 289 2010 74 80
50. A.A. Scopinho, F.H. Alves, L.B. Resstel, F.M. Correa, and C.C. Crestani Lateral septal area α1- and α2-adrenoceptors differently modulate baroreflex activity in unanaesthetized rats Exp. Physiol. 97 2012 1018 1029 10.1113/expphysiol.2011.062315
51. S.A. Engi, F.C. Cruz, R.M. Leão, F.M. Corrêa, C.S. Planeta, and C.C. Crestani Effect of the single or combined administration of cocaine and testosterone on cardiovascular function and baroreflex activity in unanesthetized rats J. Cardiovasc. Pharmacol. 59 2012 231 2340 10.1097/FJC.0b013e31823cc58b
52. H.M.1 Bronte-Stewart, A.Y. Minn, K. Rodrigues, E.L. Buckley, and L.M. Nashner Postural instability in idiopathic Parkinson's disease: the role of medication and unilateral pallidotomy Brain 125 2012 2100 2114